Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 14.31x is in line with its 1-year average of 14.69x, around the middle of its 1-year range (12.67x–16.83x).
As of Friday, July 31, 2026.
EV/EBITDA RATIO
14.31x
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
16.86x
median of 72 covered companies
CURRENT VS SECTOR MEDIAN
-15.10%
vs the sector median at left
Market Cap
$30.72B
EV/EBITDA Ratio
11.37x
TTM Avg
11.87x
3Y Avg
13.26x
5Y Avg
13.32x
Market Cap
$28.62B
EV/EBITDA Ratio
23.74x
TTM Avg
23.42x
3Y Avg
23.55x
5Y Avg
25.96x
Market Cap
$38.68B
EV/EBITDA Ratio
15.47x
TTM Avg
14.07x
3Y Avg
15.40x
5Y Avg
17.21x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $33.22B | 14.31x | N/A | N/A | N/A |
| Zoetis Inc. (ZTS)vs › | $32.40B | 9.84x | 14.43x | 20.15x | 23.01x |
| DexCom, Inc. (DXCM)vs › | $32.20B | 25.98x | 26.64x | 45.41x | 71.74x |
| Centene Corp. (CNC)vs › | $30.74B | N/A | 7.10x | 10.29x | 12.09x |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 11.37x | 11.87x | 13.26x | 13.32x |
| ResMed Inc. (RMD)vs › | $30.60B | 14.04x | 17.40x | 19.63x | 23.66x |
| Biogen Inc. (BIIB)vs › | $29.99B | 13.86x | 10.16x | 11.50x | 12.56x |
| Mettler-Toledo International Inc. (MTD)vs › | $28.62B | 23.74x | 23.42x | 23.55x | 25.96x |
| IQVIA Holdings Inc. (IQV)vs › | $38.68B | 15.47x | 14.07x | 15.40x | 17.21x |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $27.44B | 27.23x | 103.48x | 135.75x | 135.75x |
At 14.3, EV/EBITDA is in its normal range, sitting higher than 36% of its 1-year history.
1-year low
12.7
median
14.6
1-year high
16.8
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-07-30 | 14.31x |
| 2026-07-29 | 14.57x |
| 2026-07-28 | 14.69x |
| 2026-07-27 | 14.47x |
| 2026-07-24 | 14.20x |
| 2026-07-23 | 13.89x |
| 2026-07-22 | 13.77x |
| 2026-07-21 | 14.30x |
| 2026-07-20 | 14.24x |
| 2026-07-17 | 14.49x |
| 2026-07-16 | 14.86x |
| 2026-07-15 | 14.39x |
| 2026-07-14 | 14.18x |
| 2026-07-13 | 14.71x |
| 2026-07-10 | 14.84x |
| 2026-07-09 | 14.78x |
| 2026-07-08 | 14.63x |
| 2026-07-07 | 15.38x |
| 2026-07-06 | 15.31x |
| 2026-07-02 | 15.43x |
| 2026-07-01 | 15.03x |
| 2026-06-30 | 14.39x |
| 2026-06-29 | 14.44x |
| 2026-06-26 | 14.24x |
| 2026-06-25 | 13.93x |
| 2026-06-24 | 13.46x |
| 2026-06-23 | 13.25x |
| 2026-06-22 | 13.09x |
| 2026-06-18 | 13.43x |
| 2026-06-17 | 13.56x |
| 2026-06-16 | 13.74x |
| 2026-06-15 | 13.81x |
| 2026-06-12 | 13.61x |
| 2026-06-11 | 13.76x |
| 2026-06-10 | 13.59x |
| 2026-06-09 | 13.45x |
| 2026-06-08 | 12.83x |
| 2026-06-05 | 12.78x |
| 2026-06-04 | 13.01x |
| 2026-06-03 | 13.02x |
| 2026-06-02 | 12.67x |
| 2026-06-01 | 13.37x |
| 2026-05-29 | 13.60x |
| 2026-05-28 | 13.66x |
| 2026-05-27 | 13.40x |
| 2026-05-26 | 13.49x |
| 2026-05-22 | 13.72x |
| 2026-05-21 | 13.75x |
| 2026-05-20 | 13.51x |
| 2026-05-19 | 13.91x |
| 2026-05-18 | 13.45x |
| 2026-05-15 | 13.50x |
| 2026-05-14 | 14.25x |
| 2026-05-13 | 14.19x |
| 2026-05-12 | 14.15x |
| 2026-05-11 | 14.34x |
| 2026-05-08 | 14.42x |
| 2026-05-07 | 15.06x |
| 2026-05-06 | 15.11x |
| 2026-05-05 | 16.02x |
| 2026-05-04 | 15.71x |
| 2026-05-01 | 15.86x |
| 2026-04-30 | 15.79x |
| 2026-04-29 | 15.49x |
| 2026-04-28 | 15.72x |
| 2026-04-27 | 16.00x |
| 2026-04-24 | 15.87x |
| 2026-04-23 | 16.27x |
| 2026-04-22 | 16.53x |
| 2026-04-21 | 16.63x |
| 2026-04-20 | 16.83x |
| 2026-04-17 | 16.66x |
| 2026-04-16 | 16.47x |
| 2026-04-15 | 16.74x |
| 2026-04-14 | 16.67x |
| 2026-04-13 | 16.55x |
| 2026-04-10 | 16.10x |
| 2026-04-09 | 16.12x |
| 2026-04-08 | 15.75x |
| 2026-04-07 | 15.41x |
| 2026-04-06 | 15.62x |
| 2026-04-02 | 15.73x |
| 2026-04-01 | 15.66x |
| 2026-03-31 | 15.79x |
| 2026-03-30 | 15.27x |
| 2026-03-27 | 14.06x |
| 2026-03-26 | 14.28x |
| 2026-03-25 | 14.39x |
| 2026-03-24 | 14.23x |
| 2026-03-23 | 14.35x |
| 2026-03-20 | 14.41x |
| 2026-03-19 | 14.63x |
| 2026-03-18 | 14.29x |
| 2026-03-17 | 14.26x |
| 2026-03-16 | 14.16x |
| 2026-03-13 | 14.08x |
| 2026-03-12 | 13.98x |
| 2026-03-11 | 14.32x |
| 2026-03-10 | 14.45x |
| 2026-03-09 | 14.59x |
| 2026-03-06 | 14.69x |
| 2026-03-05 | 14.75x |
| 2026-03-04 | 14.45x |
| 2026-03-03 | 14.84x |
| 2026-03-02 | 15.22x |
| 2026-02-27 | 15.64x |
| 2026-02-26 | 16.00x |
| 2026-02-25 | 15.82x |
| 2026-02-24 | 16.28x |
| 2026-02-23 | 16.19x |
| 2026-02-20 | 16.24x |
| 2026-02-19 | 15.67x |
| 2026-02-18 | 15.70x |
| 2026-02-17 | 15.30x |
| 2026-02-13 | 14.88x |
| 2026-02-12 | 14.89x |
| 2026-02-11 | 15.01x |
| 2026-02-10 | 15.07x |
| 2026-02-09 | 15.61x |
| 2026-02-06 | 15.59x |
| 2026-02-05 | 15.31x |
| 2026-02-04 | 14.99x |
| 2026-02-03 | 14.92x |
| 2026-02-02 | 15.00x |
| 2026-01-30 | 14.79x |
| 2026-01-29 | 14.67x |
| 2026-01-28 | 14.82x |
| 2026-01-27 | 15.33x |
| 2026-01-26 | 14.95x |
| 2026-01-23 | 15.25x |
| 2026-01-22 | 15.24x |
| 2026-01-21 | 14.56x |
| 2026-01-20 | 14.78x |
| 2026-01-16 | 14.77x |
| 2026-01-15 | 14.40x |
| 2026-01-14 | 14.59x |
| 2026-01-13 | 14.44x |
| 2026-01-12 | 14.41x |
| 2026-01-09 | 13.84x |
| 2026-01-08 | 14.03x |
| 2026-01-07 | 13.82x |
| 2026-01-06 | 13.65x |
| 2026-01-05 | 13.45x |
| 2026-01-02 | 13.87x |
| 2025-12-31 | 14.22x |
| 2025-12-30 | 14.47x |
| 2025-12-29 | 14.48x |
| 2025-12-26 | 14.98x |
| 2025-12-24 | 15.02x |
| 2025-12-23 | 14.87x |
| 2025-12-22 | 14.53x |
| 2025-12-19 | 14.40x |
| 2025-12-18 | 13.90x |
| 2025-12-17 | 14.25x |
